Viewing Study NCT05918094


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-01-03 @ 3:07 AM
Study NCT ID: NCT05918094
Status: RECRUITING
Last Update Posted: 2024-01-26
First Post: 2023-06-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module